StockDriftsStockDriftsTop 5 Essex Woodlands Management, Inc. Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| BVS | BIOVENTUS INC | 48.35% | 13.02M | $122.9M | +0.00%(+0) | $14.34(-3.00%) | 2026-06-30 | |
| MDXG | MIMEDX GROUP INC | 42.7% | 28.20M | $108.6M | +0.00%(+0) | $8.04(-46.15%) | 2026-06-30 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 6.1% | 1.08M | $15.5M | +0.00%(+0) | $17.15(-27.70%) | 2026-06-30 | |
| TELA | TELA BIO INC | 2.28% | 7.71M | $5.8M | +0.00%(+0) | $6.82(-87.17%) | 2026-06-30 | |
| MNOV | MEDICINOVA INC | 0.57% | 1.11M | $1.5M | +0.00%(+0) | $1.70(-21.25%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | -0.81% | -2.42% | -15.50% | -56.92% |
| Top 20 Holdings Unweighted | -2.56% | -7.49% | -8.83% | -37.02% |
Essex Woodlands Management, Inc. reports $254.23M in US-listed equity holdings across 5 positions in its most recent 13F filing. Its largest disclosed positions are BVS (48.4%), MDXG (42.7%) and EYPT (6.1%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned -2.42% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Sign up free to track Essex Woodlands Management, Inc., compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Essex Woodlands Management, Inc.’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1542339). View Essex Woodlands Management, Inc.’s 13F filings on SEC